Those Recovering from Illness Strengthen immunity and speed up healing
Adverse events were mild to moderate in severity, most commonly gastrointestinal disturbance (207 adverse events, 37%), with similar rates across treatment groups
L.et al (2023a)
Cell Culture Immortalized mouse hippocampal cell line HT22 was cultivated in high-glucose DMEM (C11995500BT, Gibco, United States) containing 10% FBS (10270-106, Gibco, United States), 100 U/ml penicillin and 100 g/ml streptomycin that maintained in a 5% CO 2 incubator at 37C
The same Harding-lab science gave rise to a clinical drug candidate, fosgonimeton, also called ATH-1017, developed by a company called Athira Pharma
Keywords: Brain-gut axis, CNS-disorders, stable gastric pentadecapeptide BPC 157, therapy.